Pharmacokinetic Evaluation Of Etoricoxib 120mg Tablets In Healthy Human Pakistani Volunteers: In-Vivo In-Silico Bridging For Bioequivalence

The study demonstrated comparable systemic exposure and confirmed bioequivalence between the locally manufactured and innovator etoricoxib formulations in the Pakistani population. PBPK modeling provided supportive evidence of formulation similarity and model adequacy.